Progenics Pharmaceuticals Inc (PGNX) Directors and Executive Officers - CSIMarket
CSIMarket
 
Progenics Pharmaceuticals Inc  (PGNX)

Progenics Pharmaceuticals Inc

Officers & Directors


1. Mark R. Baker- CEO, President, and Director.
2. Timothy R. Coughlin- Chief Financial Officer and Senior Vice President.
3. Richard W. Krawiec- Executive Vice President, General Counsel, and Secretary.
4. Peter J. Crowley- Chief Scientific Officer and President.
5. Robert J. Israel- Director and Chairman of Audit Committee.
6. Paul J. Maddon- Co-Founder, former Chairman, and CEO.
Amy W. Schulman- CEO and Director.
8. Michael D. Kishbauch- Independent Director and Chairman of Regulatory Committee.
9. Patrick Fabbio- Independent Director and Chairman of Compensation Committee

Progenics Pharmaceuticals Inc currently has 100 employees.






PGNX Management Effectiveness PGNX Revenue per Employee PGNX Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.